Landos Biopharma Inc (LABP)
22.46
+0.16
(+0.72%)
USD |
NASDAQ |
May 17, 16:00
22.46
0.00 (0.00%)
After-Hours: 20:00
Landos Biopharma Total Assets (Quarterly): 29.90M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 29.90M |
| December 31, 2023 | 38.04M |
| September 30, 2023 | 43.23M |
| June 30, 2023 | 46.28M |
| March 31, 2023 | 51.18M |
| December 31, 2022 | 45.25M |
| September 30, 2022 | 49.49M |
| June 30, 2022 | 58.04M |
| Date | Value |
|---|---|
| March 31, 2022 | 77.61M |
| December 31, 2021 | 92.88M |
| September 30, 2021 | 105.10M |
| June 30, 2021 | 118.29M |
| March 31, 2021 | 110.21M |
| December 31, 2020 | 30.33M |
| September 30, 2020 | 36.76M |
| December 31, 2019 | 50.48M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
29.90M
Minimum
Mar 2024
118.29M
Maximum
Jun 2021
61.44M
Average
49.98M
Median
Total Assets (Quarterly) Benchmarks
| AbbVie Inc | 148.87B |
| Fusion Pharmaceuticals Inc | 323.81M |
| Masimo Corp | 2.958B |
| Kinnate Biopharma Inc (DELISTED) | 173.60M |
| Invivyd Inc | 215.47M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 6.742M |
| Shareholders Equity (Quarterly) | 23.15M |